Display Settings:

Format

Send to:

Choose Destination
J Clin Oncol. 2012 Jun 20;30(18):2179-82. doi: 10.1200/JCO.2012.42.0695. Epub 2012 May 21.

Choosing the best trastuzumab-based adjuvant chemotherapy regimen: should we abandon anthracyclines?

Author information

  • 1Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. hburstein@partners.org

Comment in

PMID:
22614986
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk